BERTOLDO, Francesco
 Distribuzione geografica
Continente #
NA - Nord America 7.625
EU - Europa 7.433
AS - Asia 5.577
SA - Sud America 849
AF - Africa 153
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 5
Totale 21.657
Nazione #
US - Stati Uniti d'America 7.523
RU - Federazione Russa 2.366
SG - Singapore 2.273
GB - Regno Unito 1.997
CN - Cina 1.633
IT - Italia 787
BR - Brasile 686
VN - Vietnam 504
HK - Hong Kong 460
SE - Svezia 441
FR - Francia 414
DE - Germania 413
FI - Finlandia 350
IE - Irlanda 324
KR - Corea 178
UA - Ucraina 112
IN - India 92
TR - Turchia 84
ID - Indonesia 65
AR - Argentina 58
NL - Olanda 49
CA - Canada 45
BD - Bangladesh 44
JP - Giappone 43
NG - Nigeria 43
MX - Messico 37
AE - Emirati Arabi Uniti 34
ZA - Sudafrica 34
IQ - Iraq 27
EC - Ecuador 26
ES - Italia 24
PL - Polonia 20
CL - Cile 18
RO - Romania 18
PK - Pakistan 17
AT - Austria 16
BE - Belgio 16
PH - Filippine 16
VE - Venezuela 16
CO - Colombia 15
EG - Egitto 15
EE - Estonia 13
AU - Australia 12
IR - Iran 12
LT - Lituania 12
PY - Paraguay 12
CZ - Repubblica Ceca 11
MY - Malesia 11
MA - Marocco 10
UZ - Uzbekistan 10
BJ - Benin 9
JO - Giordania 9
KE - Kenya 9
DZ - Algeria 8
IL - Israele 8
OM - Oman 8
HR - Croazia 7
PE - Perù 7
SK - Slovacchia (Repubblica Slovacca) 7
CR - Costa Rica 6
SA - Arabia Saudita 6
UY - Uruguay 6
BH - Bahrain 5
BO - Bolivia 5
TG - Togo 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AM - Armenia 4
BG - Bulgaria 4
CH - Svizzera 4
GA - Gabon 4
HU - Ungheria 4
KZ - Kazakistan 4
LB - Libano 4
LV - Lettonia 4
RS - Serbia 4
DK - Danimarca 3
DO - Repubblica Dominicana 3
GE - Georgia 3
JM - Giamaica 3
SI - Slovenia 3
SN - Senegal 3
SY - Repubblica araba siriana 3
TN - Tunisia 3
TW - Taiwan 3
AL - Albania 2
AZ - Azerbaigian 2
HN - Honduras 2
IS - Islanda 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
PT - Portogallo 2
TH - Thailandia 2
AO - Angola 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
Totale 21.635
Città #
Southend 1.775
Singapore 1.200
Jacksonville 979
Chandler 816
Ashburn 710
Moscow 698
San Jose 690
Dallas 600
Hong Kong 448
Ann Arbor 388
Woodbridge 377
Dublin 321
Houston 320
Verona 278
Beijing 210
The Dalles 193
Ho Chi Minh City 166
Princeton 149
Lawrence 148
New York 138
Wilmington 137
Nanjing 124
Los Angeles 120
Hanoi 109
Jinan 109
Shenyang 97
Buffalo 84
Milan 83
Helsinki 76
Hebei 74
Changsha 69
Sindelfingen 69
Boardman 68
Tianjin 67
São Paulo 63
Munich 54
Nanchang 53
Council Bluffs 51
Redondo Beach 51
Ningbo 48
Orem 46
Bologna 43
Zhengzhou 41
Abuja 40
London 40
Tokyo 40
Santa Clara 39
Taizhou 36
Haikou 35
Jakarta 35
Hangzhou 33
Jiaxing 33
Chicago 30
Da Nang 28
San Francisco 28
Dearborn 27
Columbus 26
Guangzhou 26
Rome 26
Lancaster 24
Frankfurt am Main 23
Rio de Janeiro 22
Montreal 21
Falls Church 19
Johannesburg 19
Turku 19
Haiphong 18
Norwalk 18
Amsterdam 17
Fuzhou 17
Paris 17
Seoul 17
Atlanta 16
Brussels 16
Chennai 16
Detroit 16
Dong Ket 16
Phoenix 16
Stockholm 16
Taiyuan 16
Curitiba 15
Lappeenranta 15
Mexico City 15
Seattle 15
Warsaw 15
Belo Horizonte 14
Biên Hòa 14
Brooklyn 14
Boston 13
Dhaka 13
Manchester 13
Denver 12
Mumbai 12
Redmond 12
Brasília 11
Falkenstein 11
Lanzhou 11
Nuremberg 11
Washington 11
Fairfield 10
Totale 13.498
Nome #
Amino-bisphosphonates decrease hTERT gene expression in breast cancer in vitro. 272
The effect of risedronate on osteogenic lineage is mediated by cyclooxygenase-2 gene upregulation 264
Gene expression analysis in osteoblastic differentiation from peripheral blood mesenchymal stem cells 253
Adipocytes IGFBP-2 expression in prepubertal obese children. 245
25-hydroxyvitamin D levels in healthy premenopausal wome: association with bone turnover markers and bone mineral density 241
The effects of menopause and estrogen replacement therapy on the renal handling of calcium 239
The effects on hTERT gene expression is an additional mechanism of amino-bisphosphonates in prostatic cancer cells 236
Age-related bone loss in postmenopausal women 231
Cathepsin K expression in castration-resistant prostate carcinoma: a therapeutical target for patients at risk for bone metastases 229
STEAP mRNA detection in serum of patients with solid tumours. 227
Trattamento dell'osteoporosi cortisonica con Nandrolone Decanoato 226
Type VI Osteogenesis imperfecta: effect of plasma transfusion on bone metabolism 219
Bone metabolism in patients with anorexia nervosa and amenorrhoea 218
Risedronate prevents the loss of microarchitecture in glucocorticoid-induced osteoporosis in rats. 214
Magnitude of PD-1, PD-L1 and T Lymphocyte Expression on Tissue from Castration-Resistant Prostate Adenocarcinoma: An Exploratory Analysis 214
BISPHOSPHONATES DECREASE HTERT IN PC3 AND DU-145 PROSTATE CANCER CELLS 212
A histomorphometric long-term longitudinal study of trabecular bone loss in glucocorticoid-treated patients: Prednisone versus Deflazacort. 207
Is vitamin D deficiency a risk factor for osteonecrosis of the jaw in patients with cancer? A matched case-control study. 201
Incidenza di ipovitaminosi D nel Nord Italia 197
Methods to identify molecular expression of mTOR pathway: a rationale approach to stratify patients affected by clear cell renal cell carcinoma for more likely response to mTOR inhibitors. 192
Altered bone metabolism in children infected with human immunodeficiency virus. 189
Medication-Related Osteonecrosis of Jaws (MRONJ) Prevention and Diagnosis: Italian Consensus Update 2020 189
Bone development during GH and GnRH analog treatment 188
Treatment with neridronate in children and adolescents with osteogenesis imperfecta: Data from open-label, not controlled, three-year Italian study 187
Acute Effects of Glucocorticoid Treatment, TNFα or IL-6R Blockade on Bone Turnover Markers and Wnt Inhibitors in Early Rheumatoid Arthritis: A Pilot Study 186
Histomorphometric analysis of glucocorticoid-induced osteoporosis 184
Duration of the effects of intravenous alendronate in postmenopausal women and in patients with primary hyperparathyroidism and Paget's disease of bone 182
The effect of bisphosphonates on gene expression: GAPDH as a housekeeping or a new target gene? 175
[Use of nonsteroidal anti-inflammatory drugs in patients with vertebral osteoporotic fractures]. 175
Guidelines for the diagnosis, prevention and management of osteoporosis 175
Blood ionized calcium is associated with clustered polymorphism in the carboxyl-terminal tail of the calcium-sensing receptor. 174
Bisphosphonates and osteonecrosis of the mandible/maxilla in osteoporosis: no reason to panic 173
Bone microarchitecture evaluated by histomorphometry 172
Prevalence of asymptomatic vertebral fractures in late-onset Pompe disease. 170
ARTROPATIE DISMETABOLICHE 168
Bone mineral metabolism in girls with precocious puberty during gonadotrophin-releasing hormone agonist treatment 166
Acute effects of deflazacort and prednisone on rates of mineralization and bone formation 164
In psoriatic arthritis Dkk-1 and PTH are lower than in rheumatoid arthritis and healthy controls 164
Bisfosfonati e metastasi ossee:up-to-date 2005 163
Regulation of calcium-parathyroid hormone feedback in primary hyperparathyroidism: effects of bisphosphonate treatment 161
Bone Microarchitecture in Mild Primary Hyperparathyroidism 159
Osteopenia induced by immunosuppressive drugs in rats. Histomorphometric analisys of risedronate effects. 156
[Evidences of safety and tolerability of the zoledronic acid 5 mg yearly in the post-menopausal osteoporosis: the HORIZON project] 154
Hypophosphatasia in adults: A new manifestation, a new mutation. A case report 154
GAPDH: CONSTITUTIVE HOUSEKEEPING GENE OR TARGET FOR THERAPEUTIC INTERVENTION? 153
Artropatie dismetaboliche 153
emerging drugs for the management of cancer treatment induced bone loss 153
Bone mass at final height in precocious puberty after gonadotropin-releasing hormone agonist with and without calcium supplementation. 149
Bisphosphonates and osteomyelitis of the jaw: a pathogenic puzzle. 149
Long-term Effects of Neridronate in Adults with Osteogenesis Imperfecta: An Observational Three-Year Italian Study 149
The renal handling of calcium: influence of parathyroid hormone secretion 148
Effects of a 4400 km ultra-cycling non-competitive race and related training on body composition and circulating progenitors differentiation 147
Vitamin D supplementation in the prevention and management of major chronic diseases not related to mineral homeostasis in adults: research for evidence and a scientific statement from the European society for clinical and economic aspects of osteoporosis and osteoarthritis (ESCEO) 147
Impact of the Visceral Adipose Tissue on Bone Quality in Patients with Untreated mild-to-severe Obstructive Sleep Apnoea 145
Biology and Pathophysiology of Bone Metastasis in Prostate Cancer 144
Effect of bisphosphonate therapy and parathyroidectomy on the urinary excretion of galactosylhydroxylysine in primary hyperparathyroidism. 143
Drug-induced osteonecrosis of the jaw: the state of the art 143
YEARS BOOK 2006 . BISFOSFONATI E ONCOLOGIA 142
Effects of two oral doses of alendronate in the treatment of Paget's disease of bone 141
Incidenza di ipovitaminosi D nel Nord Italia 141
PEAK BONE MASS AND BODY COMPOSITION IN PRECOCIOUS PUBERTY AFTER GNRH AGONIST THERAPY WITH AND WITHOUT CALCIUM SUPPLEMENTATION 140
Bone Mineral Density in Mountain, Road Cyclists and Untrained Controls: Exercise, Diet and Hormones 138
Predictive role of changes in the tumor burden and International Metastatic Renal Cell Carcinoma Database Consortium class during active surveillance for metastatic renal cell carcinoma 138
CALCIUM SUPPLEMENTATION, OESTROGENS AND BONE DENSITY IN GNRHA TREATED PRECOCIOUS PUBERTY 137
Vitamin D levels strongly influence bone mineral density and bone turnover markers during weight gain in female patients with anorexia nervosa 137
EFFETTO DI UN AGONISTA DEL GNRH AD AZIONE PROLUNGATA (LEUPROLIDE ACETATO) SULLO STATO DI MINERALIZZAZIONE OSSEA IN BAMBINE CON PUBERTA' PRECOCE 136
Bone mineral density and metabolism in HIV-infected children 136
The prevention of corticosteroid-induced osteoporosis with nandrolone decanoate 136
Effect of bisphosphonate therapy and parathyroidectomy on the urinary excretion of galactosylhydroxylysine in primary hyperparathyroidism. 135
Valutazione della microarchitettura ossea nell'iperparatiroidismo primitivo 134
Post-diagnosis serum 25-hydroxyvitamin D concentrations in women treated for breast cancer participating in a lifestyle trial in Italy 132
the use of dichloromethylene bisphosphonate and aminobutane bisphosphonate in hypercalcemnia of malignanacy 132
Transdermal Estradiol in the treatment of postmenopausale bone loss. 132
The prevention of corticosteroid-induced osteoporosis with nandrolone decantate Bone and Mineral 15, 72-81 (1991) 132
Regulation of calcium-parathyroid hormone feedback in primary htperparathyroidism effcts of bisphosphonate treatment 132
Osteomalacia: The missing link in the pathogenesis of Bisphosphonate-related osteonecrosis of the jaws? 131
The use of dichloromethylene bisphosphonate and aminobutanebisphosphonate in hypercalcemia of malignancy. 130
Physiopatology of bone metastases 129
Serum 25-hydroxy vitamin D and exercise capacity in COPD. 127
Final peak bone mass in precocious puberty after GhRH agonist therapy with and without calcium supplementation 126
The Effect of Bisphosphonates on Gene Expression: The GAPDH as a Housekeeping or a New Target Gene? 125
Sodium requirements regulates renal tubular reabsorption of calcium 125
Effects of two oral doses of alendronate in the treatment of Paget’s disease of bone. 125
The epidemiology of osteoporosis in Italian postmenopausal women according to the National Bone Health Alliance (NBHA) diagnostic criteria: a multicenter cohort study 125
Relationship between serum calcium, sodium excretion and calcium excretion in normals and in patients with idiopathic hypercalcemia and with primary hyperparathyroidism 124
Calcium Supplementation Increases Bone Mass in GH-Deficient Prepubertal Children during GH Replacement 124
Transdermal estradiol in the treatment of postmenopausal bone loss. 123
intramuscolar neridronate in postmenopausal women with low bone mineral density 123
A pragmatic window of opportunity to minimise the risk of MRONJ development in individuals with osteoporosis on Denosumab therapy: a hypothesis 122
Effetto dell'alendronato sulle caratteristiche strutturali e biomeccaniche dell'osso corticale 121
Ruolo dei bisfosfonati nella terapia dell'osteoporosi 121
Treatment thresholds for osteoporosis and reimbursability criteria: perspectives associated with fracture risk-assessment tools. 120
Relationship between serum calcium, sodium excretion and calcium excretion in normals and in patients with idiophatic hypercalciuria and primary hyperparathyroidism 119
HIV-infected children and bone mineral density 118
Use of nonsteroidal anti-inflammatory drugs in patients with vertebral osteopororis fractures 117
Valutazione della perdita frazionaria di massa ossea dopo la menopausa. 115
The prevention of corticosteroid-induced osteoporosis with nandrolone decanoate 115
Bone metastases in soft tissue sarcoma: a survey of natural history, prognostic value and treatment options. 115
Comment on Medication-Related Osteonecrosis of the Jaw: MASCC/ISOO/ASCO Clinical Practice Guideline Summary 115
Fisiopatologia del dolore da metastasi ossea 114
Totale 16.088
Categoria #
all - tutte 70.057
article - articoli 61.945
book - libri 1.170
conference - conferenze 3.483
curatela - curatele 0
other - altro 230
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.229
Totale 140.114


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021176 0 0 0 0 0 0 0 0 0 6 132 38
2021/20221.251 96 389 6 101 48 48 14 61 39 27 122 300
2022/20232.308 218 196 274 364 227 524 12 134 240 24 73 22
2023/20241.191 53 89 131 135 170 169 59 74 7 50 159 95
2024/20253.153 188 199 113 478 170 75 182 184 461 228 213 662
2025/20268.247 640 469 763 1.356 2.035 550 813 493 759 369 0 0
Totale 21.820